1 Castano L, Eisenbarth GS.Type -I diabetes:a chronic autoimmune disease of human, mouse, and rat[J].Annu Rev Immunol,1990;8:647-79
2 Birk OS, Douek DC, Elias D, Takacs K, Dewchand H, Gur SL, et al.A role of Hsp60 in autoimmune diabetes:analysis in a transgenic model[J].Proc Natl Acad Sci USA, 1996;93:1032-7
3 Elias D, Reshef T, Birk OS, Van der Zee R, WalkerMD, Cohen IR.Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kD heat shock protein[J].Proc Natl Acad Sci USA, 88:3088
4 Elias D, Markovits D, Reshef T, van der Zee R, Cohen IR.Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD Lt) mouse by a 65-kD heat shock protein[J].Proc Natl Acad Sci USA, 1990;87:1576-80
5 Birk OS, Elias D, Weiss AS, Rosen A, van-der-Zee R, Walker MD, et al.NOD mouse diabetes:the ubiquitous mouse Hsp60 is a beta-cell target antigen of autoimmune T cells[J].Autoimmunity , 1996;9:159-66
6 Elias D, Cohen IR.Peptide therapy for diabetes in NOD mice[J].Lance, 1994;343:704-6
7 Elias D, Marcus H, Reshef T, Ablamunits V, Cohen IR.Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kD heat shock protein[J].Eur J Immunol,1995;25:2851-57
8 Ruth Maron, Weiner MD.Mucosal administration of Hsp65 decreases atherosclerosis and inflammation in aortic arch of lowdensity lipoprotein receptor-deficient mice [J].Circulation,2002;106:1708-15
9 Qi GF, Mao D, Wu J, Zhong PL, Zong L, Rouel SR, et al.Long-lasting specific against CETPinduced by subcutaneous and mucosal administration of a 26-amino acid CETPepitope carried by heat shock protein 65-kD in the absence of adjuvants[J].Vaccine, 2004;22:3187-94
10 Jinshu X, Jingjing L, Duan P, Zheng Z, Ming D, Jie W, et al.The immunogenicity of recombinant and dimeric gonadotrophin-releasing hormone vaccines incorporating a T-helper epitope and GnRH or repeated GnRH units[J].J Immuno Methods,2004;289:111-2
11 Elias D, Meilin A, Ablamunits V, Birk OS, Carmi P, Konen-Waisman S, et al.Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens[J].Diabetes, 1997;46:758-64
12 Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen I.β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277):a randomised,double-blind, phase II trial[J].Lancet, 2001;358:1749-53
13 Elias D Cohen IR:Treatment or autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277[J]. protein 60 peptide p277[J].Diabetes, 1995;44:1132-38
14 Panina-Borgignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A.Universally immunogenic T cell epitopes promiscuous binding to human MHC class II and promiscuous recognition by T cells[J].Eur J Immunol, 1989;19:2237-42
15 Perraut R, Lussow AR, Gavoille S, Garraud O, Matile H, Gysin J, et al.Successful primate immunization with peptides conjugated to purified protein derivative or my cobacterial heat shock proteins in the absence of adjuvants[J].Clin ExPImmunol,1993;93:382-6
16 Thau R.Anti-LHRH and anti-pituitary gonadotropin vaccines:their development and clinical applications [J].Scand J Immunol Suppl, 1992;11:127-30
17 Faria AMC, Weiner HL.Oral tolerance:mechanisms and therapeutic applications[J].Adv Immunol, 1999;73:153-264 |
